Dallas-based Sendero has acquired Plano AI and analytics firm Torq in an eight-figure deal that adds about 90 consultants and lifts combined revenue into the nine-figure range.

argenx agreed to buy Dallas‑based Forte for about $2.2 billion, folding Forte’s experimental anti‑CD122 drug FB102 into argenx’s immunology lineup.

A split 5th Circuit panel halted Texas’ monitoring-and-filtering mandate in the SCOPE Act while leaving age‑verification rules intact.